Key Highlights
- 43.45 was the relative volume for Fractyl Health (NASDAQ:GUTS) as it fell 48% to USD 2.17 from USD 4.16, per published market data (October 16, 2026 premarket). The decline followed a co-primary endpoint win in the REMAIN-1 trial, and the 8-K discloses no financing.
- 8.15 was the relative volume for Educational Development Corporation (NASDAQ:EDUC) as it fell 16.5% to USD 1.09 on 72,900 shares. Second quarter revenue was USD 4.07 million, down 11.9%, with a net loss of USD 1.58 million, per the October 14, 2026 release.
- 3.73 was the relative volume for MDxHealth (NASDAQ:MDXH), which fell 40% premarket to USD 0.3601 after preliminary third quarter revenue of USD 22.7 million missed the USD 24.55 million consensus by 7.5% and full-year guidance was suspended.
- 3.13 was the relative volume for eXoZymes (NASDAQ:EXOZ) as it fell 13.04% to USD 4.00, 55.5% below the USD 8.99 June offering price, own arithmetic. A warrant reset to USD 0.001 applies if equity is sold below USD 8.99 before June 5, 2027.
Fractyl Health (NASDAQ:GUTS)
On October 16, 2026, Fractyl Health reported six-month REMAIN-1 data for 308 adults: mean weight regain of 5.1% for Revita against 8.2% for sham, a co-primary endpoint win with a p-value of 0.0023, per the company release. The shares fell 48% to USD 2.17 from the October 15 close of USD 4.16, own arithmetic, on 8.52 million shares against an implied average of 196,000, which produces the 43.45 relative volume. Turnover was USD 18.5 million, 33.5% of the USD 55.18 million market capitalization, own arithmetic. Neither the release nor the 8-K states a cause, so any explanation is interpretation: the gap is 3.1 percentage points, the 3.8% regain in ablations of 20 centimeters or more is a post hoc subgroup, and the 12-month endpoint reads out in the first quarter of 2027. Cash was USD 47.1 million at June 30, 2026, with substantial doubt regarding going concern per the 10-Q, a runway of 7.4 months to mid-February 2027, own arithmetic. The at-the-market program ended in March 2026, so new funding means selling shares or warrants, which dilutes holders.
Educational Development Corporation (NASDAQ:EDUC)
Educational Development Corporation reported second quarter fiscal 2027 results on October 14, 2026: net revenue of USD 4.07 million, down 11.9% from USD 4.62 million, and a net loss of USD 1.58 million, or USD 0.19 per share, per the company release. Average active PaperPie Brand Partners fell to 5,100 from 5,800, and cash declined to USD 1.2 million at August 31, 2026 from USD 1.8 million at May 31. The shares fell 16.5% to USD 1.09 on 72,900 shares against an implied average of 8,945, so a relative volume of 8.15 is a small absolute number. Turnover was USD 79,461, 0.9% of the USD 9.29 million market capitalization, own arithmetic. Published market data lists earnings per share of USD 0.20, which conflicts with the reported loss and is not reconciled. The price is 9.0% above the Nasdaq USD 1.00 minimum bid, and no deficiency notice was identified. Inventory was USD 36.2 million at May 31, 2026, the main asset convertible to cash, and falling sales slow that conversion.
MDxHealth (NASDAQ:MDXH)
MDxHealth announced preliminary third quarter revenue of USD 22.7 million on October 15, 2026, flat on the prior year and 7.5% below the USD 24.55 million published consensus, own arithmetic on two published numbers. It suspended full-year revenue guidance of USD 110 million to USD 115 million, citing unexpected sales force turnover. Diagnostics revenue depends on physician orders, so lost representatives cut volume until territories are refilled: tissue test volume fell 11% to 11,232, while Exo mdx volume rose to 11,792 from 4,600. The shares fell 40% premarket to USD 0.3601 from USD 0.6036 on 975,570 shares against an implied average of 261,500. Turnover was USD 351,000, 1.0% of the USD 34.36 million market capitalization, own arithmetic. Non-current loans were USD 96.4 million at June 30, equity was negative USD 30.4 million, and cash was USD 31.7 million at September 30. Lake Street and Craig-Hallum moved to Hold on October 16, 2026. The Nasdaq minimum bid cure period from the July 2 notice ends December 29, 2026, own arithmetic.
eXoZymes (NASDAQ:EXOZ)
eXoZymes fell 13.04% to USD 4.00 from an implied prior close of USD 4.60, own arithmetic, on 24,360 shares at relative volume of 3.13, an implied average of 7,783. Turnover was USD 97,440, 0.26% of the USD 37.13 million market capitalization, own arithmetic. The price is 55.5% below the USD 8.99 June 2026 offering, which closed 330,575 units for gross proceeds of USD 5.95 million. The warrants reset to a USD 0.001 exercise price if the company sells equity below USD 8.99 before June 5, 2027, so a raise at current levels would let qualifying holders convert 330,575 warrants for USD 331 into shares worth USD 1.32 million at USD 4.00, own arithmetic. An 8-K filed on October 9, 2026 furnished an October 6 investor presentation that may be shown to bankers and offering participants; it announces no offering. Cash of USD 5.65 million is not matched to a filing reviewed and implies a runway of 6.1 months, own arithmetic on trailing earnings per share. No company-specific catalyst was identified in the filings and releases reviewed through October 16, 2026. Heavy relative volume here may reflect holders pricing in dilution, which is an inference on a small absolute volume.
Where Things Stand
Fractyl Health (NASDAQ:GUTS) traded at 43 times normal volume after a 48% fall that followed an endpoint win and has no stated cause. Educational Development Corporation (NASDAQ:EDUC) ranks second at 8.15, on only 72,900 shares. MDxHealth (NASDAQ:MDXH) ranks third at 3.73, with a documented guidance suspension behind it. eXoZymes (NASDAQ:EXOZ) ranks fourth at 3.13, a spread of 13.9 times from top to bottom, own arithmetic. By turnover as a share of market capitalization the order is Fractyl Health 33.5%, MDxHealth 1.0%, Educational Development 0.9% and eXoZymes 0.26%, own arithmetic. Next dated events are the October 20, 2026 lead plaintiff deadline and the MDxHealth call on November 12, 2026.






Please wait processing your request...